Cargando…

Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation

BACKGROUND: Circulating endothelial progenitor cells (EPCs) capture technology improves endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re-endothelialization, as well as endothelial dysfunction, has still not been overcome. Therefore, we investigated whether th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feng, Feng, Shi-Chao, Pang, Xiang-Jun, Li, Wei-Xiao, Bi, Yong-Hua, Zhao, Qian, Zhang, Shi-Xuan, Wang, Yang, Feng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506512/
https://www.ncbi.nlm.nih.gov/pubmed/23098083
http://dx.doi.org/10.1186/1471-2261-12-96
_version_ 1782250919096745984
author Yang, Feng
Feng, Shi-Chao
Pang, Xiang-Jun
Li, Wei-Xiao
Bi, Yong-Hua
Zhao, Qian
Zhang, Shi-Xuan
Wang, Yang
Feng, Bo
author_facet Yang, Feng
Feng, Shi-Chao
Pang, Xiang-Jun
Li, Wei-Xiao
Bi, Yong-Hua
Zhao, Qian
Zhang, Shi-Xuan
Wang, Yang
Feng, Bo
author_sort Yang, Feng
collection PubMed
description BACKGROUND: Circulating endothelial progenitor cells (EPCs) capture technology improves endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re-endothelialization, as well as endothelial dysfunction, has still not been overcome. Therefore, we investigated whether the combination coating of hyaluronan-chitosan (HC) and anti-CD34 antibody applied on an SES (HCASES) can promote endothelialization, while reducing neointimal formation and inflammation. METHODS: Sirolimus-eluting stents(SES), anti-CD34 antibody stents (GS) and HC-anti-CD34 antibody combined with sirolimus-eluting stents (HCASES) were deployed in 54 normal porcine arteries and harvested for scanning electron microscopy (SEM) and histological analysis. The ratio of endothelial coverage above the stents was evaluated by SEM analysis at 7, 14 and 28 days. The percentage of in-stent stenosis was histologically analyzed at 14 and 28 days. RESULTS: SEM analysis at 7 days showed that endothelial strut coverage was increased in the HCASES group (68±7%) compared with that in the SES group (31±4%, p=0.02). At 14 days, stent surface endothelialization, evaluated by SEM, showed a significantly higher extent of endothelial coverage above struts in the GS (95 ± 2%) and the HCASES groups (87±4%) compared with that in the SES group (51±6%, p=0.02). Histological examination showed that the percentage of stenosis in the HCASES group was not significantly different to that of the SES and GS groups (both p> 0.05). At 28 days, there was no difference in the rates of endothelial coverage between the HCASES and GS groups. The HCASES group showed less stenosis than that in the GS group (P < 0.05), but it was not significantly different from the SES group (P=0.068). CONCLUSIONS: SEM and histology demonstrated that HCASESs can promote re-endothelialization while enhancing antiproliferative effects.
format Online
Article
Text
id pubmed-3506512
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35065122012-11-27 Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation Yang, Feng Feng, Shi-Chao Pang, Xiang-Jun Li, Wei-Xiao Bi, Yong-Hua Zhao, Qian Zhang, Shi-Xuan Wang, Yang Feng, Bo BMC Cardiovasc Disord Research Article BACKGROUND: Circulating endothelial progenitor cells (EPCs) capture technology improves endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re-endothelialization, as well as endothelial dysfunction, has still not been overcome. Therefore, we investigated whether the combination coating of hyaluronan-chitosan (HC) and anti-CD34 antibody applied on an SES (HCASES) can promote endothelialization, while reducing neointimal formation and inflammation. METHODS: Sirolimus-eluting stents(SES), anti-CD34 antibody stents (GS) and HC-anti-CD34 antibody combined with sirolimus-eluting stents (HCASES) were deployed in 54 normal porcine arteries and harvested for scanning electron microscopy (SEM) and histological analysis. The ratio of endothelial coverage above the stents was evaluated by SEM analysis at 7, 14 and 28 days. The percentage of in-stent stenosis was histologically analyzed at 14 and 28 days. RESULTS: SEM analysis at 7 days showed that endothelial strut coverage was increased in the HCASES group (68±7%) compared with that in the SES group (31±4%, p=0.02). At 14 days, stent surface endothelialization, evaluated by SEM, showed a significantly higher extent of endothelial coverage above struts in the GS (95 ± 2%) and the HCASES groups (87±4%) compared with that in the SES group (51±6%, p=0.02). Histological examination showed that the percentage of stenosis in the HCASES group was not significantly different to that of the SES and GS groups (both p> 0.05). At 28 days, there was no difference in the rates of endothelial coverage between the HCASES and GS groups. The HCASES group showed less stenosis than that in the GS group (P < 0.05), but it was not significantly different from the SES group (P=0.068). CONCLUSIONS: SEM and histology demonstrated that HCASESs can promote re-endothelialization while enhancing antiproliferative effects. BioMed Central 2012-10-26 /pmc/articles/PMC3506512/ /pubmed/23098083 http://dx.doi.org/10.1186/1471-2261-12-96 Text en Copyright ©2012 Yang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Feng
Feng, Shi-Chao
Pang, Xiang-Jun
Li, Wei-Xiao
Bi, Yong-Hua
Zhao, Qian
Zhang, Shi-Xuan
Wang, Yang
Feng, Bo
Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
title Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
title_full Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
title_fullStr Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
title_full_unstemmed Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
title_short Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
title_sort combination coating of chitosan and anti-cd34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506512/
https://www.ncbi.nlm.nih.gov/pubmed/23098083
http://dx.doi.org/10.1186/1471-2261-12-96
work_keys_str_mv AT yangfeng combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT fengshichao combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT pangxiangjun combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT liweixiao combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT biyonghua combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT zhaoqian combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT zhangshixuan combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT wangyang combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation
AT fengbo combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation